Disposable Surgical Devices Market Growth & Trends:
The global disposable surgical devices market size is expected to reach USD 10.1 billion by 2030, according to a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 8.2% from 2023 to 2030. The growing prevalence of chronic diseases, such as cardiovascular, neurological, urological, and infectious disorders, is expected to drive the overall market. Chronic diseases are a global healthcare concern, with over half of the adult population in the U.S. suffering from them, resulting in over 75% of the total healthcare expenditure. Thus, a rise in infectious and chronic diseases is expected to create a significant demand for disposable surgical devices.
Cancer has become a significant healthcare burden and a leading cause of death across the globe. According to the WHO, almost 1 in 6 deaths can be attributed to this disease. Estimates from the same source indicate that over 70% of cancer-related deaths typically occur in middle- and low-income countries. Thus, a steady rise in the number of curative, preventive, and diagnostic cancer surgeries has been observed globally, creating a high demand for disposable surgical equipment.
The growing number of road accidents is expected to augment the demand for disposable surgical instruments. According to the WHO, around 10 million people are injured or disabled due to road accidents every year, creating a demand for surgeries. Such wounds are commonly managed using surgical sutures. Hence, the increasing number of road accidents is expected to positively impact demand for disposable surgical sutures and staplers.
The increasing government initiatives for the usage of disposable medical devices to avoid hospital-associated infections are expected to boost the usage of single-use devices. The growing number of surgical procedures is expected to increase the need for disposable surgical devices.
Disposable Surgical Devices Market Report Highlights:
- Based on product, surgical sutures and staplers held the largest share of 45.0% in 2022. Electrosurgical devices are expected to grow at the fastest rate of 9.0% over the forecast period. Electrosurgical instruments help perform surgeries in ambulatory surgical centers (ASCs) or clinics without the need for hospital settings.
- By application, General surgery held the largest share of 23.3% in 2022. The growth of this segment is driven by the increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders, which demand surgical interventions.
- The plastic and reconstructive surgery segment is expected to grow at the fastest rate of 9.0% over the forecast period. The growing number of plastic surgeries in various countries, such as the U.S., Brazil, and Mexico, is expected to propel the need for disposable surgical devices for the same
- North America held the largest share of 29.7% in 2022. This can be attributed to the increasing incidence of chronic diseases, such as cardiovascular and neurological diseases, cancer, diabetes, and autoimmune diseases.
- The Asia Pacific segment is expected to grow significantly during the forecast period. A large patient pool in the region is expected to contribute to the regional market growth.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Disposable Surgical Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Disposable Surgical Devices Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Disposable Surgical Devices: By Product Estimates & Trend Analysis
- 4.1. Disposable Surgical Devices Market, By Product Key Takeaways
- 4.2. Disposable Surgical Devices Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Surgical Sutures & Staplers
- 4.3.1. Surgical Sutures & Staplers market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Handheld Surgical Devices
- 4.4.1. Handheld Surgical Devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Electrosurgical Devices
- 4.5.1. Electrosurgical Devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Disposable Surgical Devices: Application Estimates & Trend Analysis
- 5.1. Disposable Surgical Devices Market, By Application Key Takeaways
- 5.2. Disposable Surgical Devices Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Neurosurgery
- 5.3.1. Neurosurgery market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Plastic & Reconstructive Surgery
- 5.4.1. Plastic & reconstructive surgery market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Wound Closure
- 5.5.1. Wound closure market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Obstetrics & Gynecology
- 5.6.1. Obstetrics & gynecology market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.7. Cardiovascular
- 5.7.1. Cardiovascular market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.8. Orthopedic
- 5.8.1. Orthopedic market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.9. General Surgery
- 5.9.1. General surgery market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.10. Others
- 5.10.1. Others surgery market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Disposable Surgical Devices Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Disposable Surgical Devices Market by Region: Key Takeaways
- 6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Denmark
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Norway
- 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
- 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. Saudi Arabia
- 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. South Africa
- 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.2.1. B. Braun SE
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Smith+Nephew
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Aspen Surgical
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. Alcon Laboratories, Inc.
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Zimmer Biomet
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Medtronic
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. BD
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Ethicon
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. CooperSurgical Inc.
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Surgical Innovations
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives